<DOC>
	<DOCNO>NCT01484873</DOCNO>
	<brief_summary>The purpose study determine whether exenatide cause weight loss patient history craniopharyngioma brain lesion .</brief_summary>
	<brief_title>Weight Loss Study Patients With Obesity Due Craniopharyngioma Other Brain Tumor</brief_title>
	<detailed_description>Hypothalamic obesity occur 60 % patient tumor hypothalamic region , commonly craniopharyngiomas . Hypothalamic dysfunction due tumor infiltration consequence surgery radiation therapy . Survivors develop obesity great morbidity mortality normal weight survivor . Prevention treatment obesity population vital order decrease morbidity mortality diabetes , stroke myocardial infarction . Exenatide ( ByettaÂ® ) GLP-1 homologue FDA approve treatment type 2 diabetes 2005 . It also decrease rate gastric emptying increase satiety show cause weight loss people . Exenatide may improve insulin sensitivity satiety patient hypothalamic obesity without risk bariatric surgery . The investigator hypothesize treatment exenatide lead weight loss patient hypothalamic obesity .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Craniopharyngioma</mesh_term>
	<mesh_term>Adamantinoma</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Age 18 40 year old History craniopharyngioma lesion hypothalamic region Greater 6 month posttreatment , include chemotherapy , surgery radiation BMI &gt; 30 mg/m2 Females must postmenopausal , surgically sterile use effective birth control least 12 week HgbA1C &gt; 7 % Use diabetes medication metformin past 12 week , include exenatide Use weight loss drug initiation weight loss program past 3 month Impaired renal function history kidney transplant History gall stone ( unless s/p cholecystectomy ) , pancreatitis alcoholism Personal family history medullary carcinoma thyroid MEN type 2 History gastroparesis gastric motility problem exenatide decrease gastric motility History allergic reaction exenatide medication component Other significant comorbidities pituitary deficiency Currently prescribe warfarin ( exenatide may alter warfarin metabolism ) Pregnant lactate female History severe hypoglycemia ( BG &lt; 60 require assistance another person )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Exenatide</keyword>
	<keyword>Byetta</keyword>
	<keyword>Hypothalamic Obesity</keyword>
	<keyword>Obesity</keyword>
	<keyword>Craniopharyngioma</keyword>
</DOC>